在手术重症监护室的早期,有目标的动员:一个随机对照试验
Stefan J Schaller1, Matthew Anstey2, Manfred Blobner1
1Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
Lancet (London, England)
|October 7, 2016
概括
在手术重症监护室 (SICU) 早期调动显著改善了患者的行动能力和功能独立性. 这种干预措施也减少了重症病人的住院时间.
科学领域:
- 危急护理医学
- 康复医学
- 手术的结果
背景情况:
- 静止与手术重症监护室 (SICU) 患者的不良结果有关.
- 尽管有潜在的好处,但早期动员的尝试往往受到限制.
- 这项研究调查了早期动员对SICU患者结果的影响.
研究的目的:
- 确定早期的,有目标的动员能否改善患者在SICU中的流动性.
- 评估早期动员对SICU停留时间的影响.
- 评估医院出院时对功能独立性的影响.
主要方法:
- 这是一项多中心随机对照试验,涉及五所大学医院的急诊病房的200名患者.
- 用SICU最佳动员分数 (SOMS) 算法将患者分配到标准护理或早期的目标导向动员方案中.
- 主要结果是达到的平均SOMS水平;次要结果包括SICU停留时间和在出院时最小修改的功能独立度量 (mmFIM).
主要成果:
- 早期调动显著改善了所达到的SOMS水平 (2.2比1.5,p<0.0001).
- 干预组的住院时间较短 (平均7天与10天,p=0. 0054).
- 干预组的功能性移动性显著改善 (mmFIM得分为8比5,p=0.0002).
结论:
- 早期,目标导向的动员是有效的改善患者在SICU入院期间的流动性.
- 这种方法减少了在SICU停留的时间.
- 早期动员可以提高患者在出院时的功能动力.
相关概念视频
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
407
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
407
Study Designs in Epidemiology
1.6K
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.6K
Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522


